Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

NCT02423954 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Investigator no longer at site to enroll patients or write up data

Conditions

Advanced Cancer
Pancreatic Cancer
Renal Cell Cancer
Non Small Cell Lung Cancer
Colorectal Carcinoma
Endometrial
Uterine

Interventions

DRUG: Temsirolimus
DRUG: Irinotecan
DRUG: Irinotecan + capecitabine
DRUG: nivolumab

Sponsor

Western Regional Medical Center